(KDLY) Kindly MD Common Stock - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •

KDLY: Prescription Medicine, Behavioral Services, Therapy Sessions

Kindly MD, Inc. operates at the intersection of healthcare delivery and data-driven insights, offering a comprehensive suite of medical and behavioral health services. The company provides specialty outpatient care on a subscription and fee-for-service model, aiming to complement traditional healthcare systems. Its clinical services include chronic pain management, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel health, and hormone therapy. Beyond clinical services, the company engages in data collection and research, digital marketing campaigns, and the retail sale of healthcare products through both physical clinics and online platforms.

Formerly known as Utah Therapeutic Health Center, LLC, the company rebranded as Kindly MD, Inc. in March 2022 to reflect its expanded scope and mission. Incorporated in 2019 and headquartered in Salt Lake City, Utah, Kindly MD, Inc. has established itself as a multi-faceted healthcare provider with a focus on integrated care and patient-centric solutions. The companys approach combines medical and behavioral health services, emphasizing a holistic model of care.

Ticker Symbol: KDLY (NASDAQ) represents the companys common stock, classified under the Health Care Services sub-industry. With a market capitalization of $7.55 million, Kindly MD, Inc. operates with a price-to-book ratio of 1.72 and a price-to-sales ratio of 2.44, reflecting its current valuation metrics. The companys return on equity stands at -84.41%, indicating significant challenges in profitability. Its forward and trailing P/E ratios are currently undefined, as the company has not reported positive earnings.

From a technical standpoint, KDLYs stock price of $1.42 is below its 20-day ($2.09) and 50-day ($1.65) moving averages, signaling bearish momentum. The 200-day moving average of $1.65 further underscores the stocks recent downward trajectory. Average trading volume over the past 20 days is 171,600 shares, with an average true range (ATR) of 0.35, indicating moderate volatility. The stocks relative strength index (RSI) is not provided but would be critical in assessing overbought or oversold conditions.

3-Month Forecast: Based on the convergence of technical and fundamental data, KDLY is likely to face continued pressure in the near term. The stocks position below key moving averages suggests bearish sentiment, while the negative return on equity raises concerns about profitability. However, the low price-to-sales ratio of 2.44 may indicate undervaluation, potentially attracting value investors. The companys ability to expand its service offerings and improve operational efficiency will be critical in determining its trajectory. Short-term price targets could range between $1.10 and $1.80, depending on market sentiment and earnings visibility.

Additional Sources for KDLY Stock

KDLY Stock Overview

Market Cap in USD 8m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2024-05-31

KDLY Stock Ratings

Growth 5y -33.9%
Fundamental -72.0%
Dividend 0.0%
Rel. Strength Industry -51.4
Analysts -
Fair Price Momentum 1.32 USD
Fair Price DCF -

KDLY Dividends

No Dividends Paid

KDLY Growth Ratios

Growth Correlation 3m 65.3%
Growth Correlation 12m -35.7%
Growth Correlation 5y -35.7%
CAGR 5y -50.33%
CAGR/Max DD 5y -0.68
Sharpe Ratio 12m -0.51
Alpha -67.34
Beta 1.97
Volatility 119.15%
Current Volume 40.9k
Average Volume 20d 99.3k
What is the price of KDLY stocks?
As of March 15, 2025, the stock is trading at USD 1.50 with a total of 40,943 shares traded.
Over the past week, the price has changed by -9.09%, over one month by -48.10%, over three months by +30.43% and over the past year by -50.33%.
Is Kindly MD Common Stock a good stock to buy?
No, based on ValueRay Fundamental Analyses, Kindly MD Common Stock (NASDAQ:KDLY) is currently (March 2025) a stock to sell. It has a ValueRay Fundamental Rating of -72.00 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDLY as of March 2025 is 1.32. This means that KDLY is currently overvalued and has a potential downside of -12%.
Is KDLY a buy, sell or hold?
Kindly MD Common Stock has no consensus analysts rating.
What are the forecast for KDLY stock price target?
According to ValueRays Forecast Model, KDLY Kindly MD Common Stock will be worth about 1.5 in March 2026. The stock is currently trading at 1.50. This means that the stock has a potential upside of +1.33%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1.5 1.3%